hg_123816.1

Basic information about the TSS

---

TSS ID: hg_123816.1 Species: human Chr: chr12		Start: 6927554 End: 6927569 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000396684.3 NM_001940 Distance: 390 GeneID: 1822 HGNC/MGI_ID: HGNC:3033 UniProt_ID: P54259

Gene_name: atrophin 1 Gene_symbol: ATN1 Gene_synonyms: B37 Gene_source: HGNC:3033

TATA-Box annotation

---

Distance to TSS:	-397
Nearest PromoterID:	NM_001940
Entrez ID:	1822
Nearest Unigene:	Hs.143766
Nearest Refseq:	NM_001940
Nearest Ensembl:	ENSG00000111676
Gene Name:	atrophin 1
Gene Alias:	B37|D12S755E|DRPLA|HRS|NOD
Gene Description:	atrophin 1
Gene Type:	protein-coding
CpG%:	0.095
GC%:	0.756219
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ATN1 p2@ATN1 p4@ATN1 p6@ATN1 p8@ATN1 p10@ATN1
Sample		p1@ATN1	p2@ATN1	p4@ATN1	p6@ATN1	p8@ATN1	p10@ATN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.42	0.39	0.19	0.97	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.94	1.01	0.81	1.21	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.54	0.39	0.77	0.96	0.39	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.06	0.83	0.62	0.62	0.62	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.72	0.22	0.67	0.90	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.27	0.00	0.58	0.78	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	16.78	1.31	0.65	0.87	0.22	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.78	0.48	0.97	1.21	0.73	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.74	0.64	0.85	0.85	0.64	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.23	1.16	1.16	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.21	1.21	0.81	0.81	1.21	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.45	1.63	0.00	0.00	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.47	1.29	0.81	0.16	1.61	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.48	1.20	0.45	0.60	0.60	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.95	1.10	0.66	0.44	0.88	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.57	1.26	0.50	0.25	1.26	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.45	0.44	0.87	0.22	0.44	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.28	1.69	0.42	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	2.13	0.00	0.00	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.54	1.35	1.20	0.45	1.50	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.83	1.60	0.80	0.40	1.20	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.60	0.86	0.69	0.52	0.52	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.76	0.39	0.26	0.39	0.65	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.10	1.94	1.46	0.49	0.00	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.16	1.55	1.55	0.77	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.19	2.85	0.00	0.00	0.95	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.74	1.10	0.00	0.55	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.32	1.41	1.18	0.94	0.94	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.05	0.81	0.48	1.13	1.13	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.67	1.81	0.18	0.36	0.72	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.26	1.47	0.42	0.84	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.77	0.98	0.59	0.59	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	1.90	0.00	0.21	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.58	1.15	0.16	0.33	0.66	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	12.15	2.06	0.37	0.00	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.46	1.34	0.77	0.38	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.81	2.04	0.61	0.82	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.65	1.01	0.20	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.10	0.54	1.35	0.27	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.40	0.72	0.96	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.47	0.71	0.71	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.54	0.44	0.59	0.44	0.15	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.69	1.27	0.42	0.00	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.87	1.57	0.52	0.35	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.62	1.41	0.40	0.00	0.60	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	5.82	1.40	0.00	0.00	0.47	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.96	0.72	0.48	0.24	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.36	0.30	0.00	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.38	1.68	0.48	1.20	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.07	1.62	0.61	0.81	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.43	1.23	0.41	0.00	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.56	0.89	0.89	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.87	0.00	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.60	1.33	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.87	0.00	0.84	0.00	2.52	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.05	1.38	0.46	0.00	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.70	1.30	0.97	0.00	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.18	2.25	0.64	0.00	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	8.80	1.57	0.63	0.00	1.26	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	0.71	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	1.68	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	2.39	1.59	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.83	1.02	0.68	0.00	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.47	0.32	0.32	0.00	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.00	1.06	0.71	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	0.49	0.49	0.00	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.97	1.49	0.50	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.44	0.94	0.00	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.27	0.33	0.66	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.52	0.93	0.31	0.00	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.17	1.83	0.00	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	11.40	1.58	0.32	0.63	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	16.20	2.41	0.64	0.64	1.12	1.28
Adipocyte - omental, donor1	11473-119C6	19.59	4.07	0.64	0.51	0.89	0.13
Adipocyte - omental, donor2	11474-119C7	15.70	2.24	0.00	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	19.76	0.67	1.34	1.67	2.68	1.34
Adipocyte - perirenal, donor1	11476-119C9	13.40	0.64	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	11.29	0.90	0.45	0.00	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	16.68	1.39	1.56	0.87	1.04	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	28.16	4.11	2.35	0.98	1.76	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	14.41	0.51	1.29	0.77	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	19.51	1.39	1.39	0.56	1.95	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	34.68	2.94	2.94	1.18	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	35.63	5.47	4.99	2.57	4.42	1.13
Adipocyte differentiation, day08, donor2	13023-139D8	18.07	2.90	2.26	2.58	0.97	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	1.60	2.67	1.07	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	18.92	3.34	0.00	1.11	5.01	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	13.31	1.66	2.91	1.66	2.08	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	13.06	0.75	1.00	0.75	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.05	1.96	1.64	1.96	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	17.96	2.74	2.44	1.83	1.22	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	17.24	2.65	0.88	1.55	0.88	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	27.25	2.15	1.79	1.08	1.43	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	3.59	0.00	0.00	1.20	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	15.29	0.54	0.36	1.80	1.62	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	16.02	1.64	1.44	1.85	1.85	0.41
Anulus Pulposus Cell, donor1	11248-116E6	21.86	1.95	1.83	1.14	1.14	1.14
Anulus Pulposus Cell, donor2	11463-119B5	28.90	1.96	3.67	3.18	1.71	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	9.44	0.45	1.80	0.00	0.45	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.99	0.43	0.43	0.87	0.87	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	2.14	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.96	0.30	0.90	0.00	1.49	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	1.26	0.00	0.00	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	0.66	1.98	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.02	0.32	0.97	0.00	0.97	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.22	1.94	0.00	0.00	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.13	1.19	0.59	0.00	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.17	0.75	1.88	1.13	1.13	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	8.71	0.73	0.73	0.73	2.90	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.57	0.82	1.32	0.16	0.82	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	1.36	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.98	0.90	0.75	0.60	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	0.54	0.54	1.61	0.00	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.45	1.51	0.94	1.51	1.70	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.89	1.34	0.27	0.80	1.07	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	0.00	2.93	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.30	0.50	1.00	0.50	1.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1.20	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.12	1.37	0.86	0.86	1.37	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.22	0.97	0.97	1.46	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.11	0.76	1.14	0.76	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	0.00	0.00	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	1.14	0.57	0.00	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.99	0.86	1.50	1.71	1.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.74	0.26	0.52	0.52	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.51	1.41	0.00	0.00	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.00	1.29	0.96	0.32	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	2.14	0.71	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	0.58	1.75	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.74	0.30	0.60	0.90	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.15	0.00	1.02	0.00	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.95	1.78	1.27	1.02	0.76	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	1.27	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.20	0.86	1.29	0.43	2.59	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.83	1.48	0.42	0.64	1.06	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.54	0.87	0.58	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	0.94	0.00	0.00	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.14	1.19	0.85	0.68	0.34	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	0.00	2.11	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.65	1.72	0.64	0.86	1.72	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	0.00	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	0.00	0.73	0.73	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.05	0.69	0.46	0.69	0.92	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.81	0.51	0.51	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.29	1.45	0.62	0.83	1.24	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.51	0.61	0.31	1.22	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.26	0.48	0.48	0.48	0.96	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.98	1.11	0.89	1.33	0.67	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	0.00	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	0.55	0.55	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.33	0.79	0.53	0.00	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.18	0.73	0.73	0.00	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	37.70	3.07	3.19	2.70	1.84	1.35
Astrocyte - cerebellum, donor2	11580-120F5	33.89	1.37	3.94	2.57	2.57	1.20
Astrocyte - cerebellum, donor3	11661-122F5	35.03	1.26	4.40	2.73	1.47	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	27.54	2.44	1.05	2.09	2.09	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	23.30	1.78	2.10	1.78	0.65	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	21.93	2.09	2.98	1.34	1.04	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	5.16	0.57	1.72	0.69	0.46	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	3.51	0.63	0.38	0.25	0.38	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	3.76	0.68	0.57	0.23	0.23	0.68
Basophils, donor1	12241-129G9	1.57	0.26	0.78	0.52	0.26	0.26
Basophils, donor2	12242-129H1	2.16	0.72	0.72	0.36	0.00	0.36
Basophils, donor3	12243-129H2	7.35	0.59	1.03	0.29	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	13.15	1.72	0.43	0.43	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	26.06	2.29	1.37	0.00	0.91	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.93	0.63	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	16.64	1.25	1.25	0.83	0.62	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	16.12	1.38	0.92	0.46	1.38	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	11.16	0.72	0.18	0.90	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.62	0.41	0.41	0.21	0.00	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.93	0.23	1.40	0.47	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1.92	0.64	1.28	1.92	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	5.07	0.56	0.56	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	3.71	0.93	0.74	0.37	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	3.73	0.88	0.88	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.23	1.13	0.85	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	4.55	0.38	0.00	0.38	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	7.56	1.64	0.33	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	3.18	0.29	0.00	0.14	0.43	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	0.91	0.00	0.30	0.00	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	1.66	0.24	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	2.01	0.33	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.66	0.28	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.99	0.25	0.00	0.50	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.74	0.39	0.20	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.36	0.00	0.18	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.52	0.00	0.00	0.00	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.04	0.00	0.70	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.64	0.53	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.78	0.15	0.15	0.00	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.40	0.20	0.00	0.40	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.25	0.21	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.69	0.46	0.00	0.92	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.04	0.45	0.23	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.87	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.08	0.00	0.81	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.40	0.17	0.35	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1.26	0.00	0.42	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.10	0.37	0.18	0.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.70	0.00	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.19	0.44	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.74	0.17	0.17	0.00	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.74	0.37	0.37	0.00	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1.29	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.28	0.82	0.82	0.00	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.39	0.23	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.23	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.44	0.65	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.92	0.23	0.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	0.43	0.22	0.00	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	2.49	0.31	0.00	0.00	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	2.27	0.17	0.00	0.17	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	3.79	0.67	0.00	0.22	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.44	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	1.04	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.53	0.00	1.07	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.07	0.00	1.61	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	0.00	2.11	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.78	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	0.82	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.73	0.00	0.73	0.73	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	3.03	0.00	2.52	1.01	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.68	1.21	1.21	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.20	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	1.69	0.00	6.18	1.12	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	0.75	0.38	1.50	0.75	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1.80	0.45	1.13	0.45	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	2.86	0.36	4.64	2.14	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	2.45	0.00	0.61	2.45	0.00	1.84
CD4+ T Cells, donor3	11382-118B5	2.74	0.30	1.22	2.13	0.30	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2.55	1.28	1.53	0.51	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.49	0.22	1.35	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	3.45	0.57	0.57	0.57	0.00	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.95	0.00	0.47	0.00	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	0.00	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.02	0.58	0.72	0.29	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	3.22	0.51	0.51	0.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	2.90	0.32	0.48	0.16	0.00	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1.79	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.35	0.35	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.44	0.00	0.00	1.32	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	4.22	0.42	0.00	1.26	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	3.12	0.42	1.66	0.62	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.00	0.00	1.34	0.33	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.82	0.00	2.45	0.54	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.54	0.54	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	0.00	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	3.15	1.11	1.11	0.56	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1.30	0.43	0.22	0.00	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	3.57	1.26	1.05	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.51	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	0.00	1.30	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.44	0.00	1.31	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.49	0.00	0.49	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1.66	0.28	0.55	0.55	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1.96	0.00	0.74	1.23	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	0.00	0.72	1.07	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	0.00	1.38	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	1.31	0.00	1.31	1.64	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	2.25	0.00	1.50	0.00	0.00	1.13
CD8+ T Cells, donor3	11383-118B6	2.02	0.50	1.51	1.51	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.92	0.00	0.46	0.46	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.48	0.00	0.00	0.48	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.09	0.00	0.55	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.20	0.00	0.30	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	1.68	0.24	0.24	0.24	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.05	0.45	0.00	0.00	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.96	0.00	0.00	0.65	0.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.90	0.53	0.26	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1.64	0.00	0.23	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.60	0.60	0.00	0.00	0.00	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1.16	0.00	0.58	0.00	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.80	0.00	0.00	0.00	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	0.00	0.00	0.44	1.75	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1.37	0.00	0.46	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.75	0.00	0.00	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1.08	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1.44	0.00	0.58	0.29	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.89	0.24	0.24	0.24	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1.90	0.00	0.32	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.38	0.31	0.31	0.31	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.96	0.32	0.00	0.64	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	0.76	0.38	0.38	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.79	0.39	0.00	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	0.76	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.80	0.00	0.80	1.61	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1.40	0.00	0.70	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	1.00	0.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	109.66	7.31	14.62	5.48	5.48	1.83
Cardiac Myocyte, donor2	11605-120I3	22.73	0.99	1.48	2.47	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	11.79	1.79	0.84	0.95	0.53	0.00
Chondrocyte - de diff, donor1	11261-116G1	25.65	2.08	1.73	0.35	2.43	1.04
Chondrocyte - de diff, donor2	11338-117F6	25.94	1.78	1.42	1.07	2.13	0.71
Chondrocyte - de diff, donor3	11410-118E6	13.99	2.28	1.59	0.68	0.91	0.80
Chondrocyte - re diff, donor2	11339-117F7	4.48	0.00	0.00	0.00	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	24.67	5.66	0.40	1.21	2.43	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	16.53	1.38	1.26	1.49	0.69	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	11.12	1.28	0.86	1.28	0.21	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	12.30	1.15	1.50	0.97	1.50	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	46.68	6.97	2.93	2.66	2.75	1.74
Corneal Epithelial Cells, donor1	11526-119I5	15.59	1.10	1.32	0.22	0.88	0.66
Corneal Epithelial Cells, donor2	11606-120I4	12.51	2.28	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	10.48	1.28	0.26	0.00	0.77	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	2.97	0.99	0.50	0.66	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4.42	1.26	0.95	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	2.92	0.54	0.22	0.11	0.32	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1.02	0.34	1.02	0.68	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.96	0.00	1.31	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1.45	0.00	0.97	2.42	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	20.51	6.34	2.50	1.33	6.17	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	1.76	4.11	2.35	2.93	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	25.17	2.83	2.55	1.13	4.81	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	23.59	3.93	1.97	2.36	6.68	0.79
Endothelial Cells - Artery, donor1	11264-116G4	18.03	2.62	1.75	2.62	5.24	0.29
Endothelial Cells - Artery, donor2	11341-117F9	20.70	3.29	3.06	1.41	4.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	18.41	4.38	1.58	2.28	3.51	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.76	2.44	1.55	1.33	3.10	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	5.17	1.22	1.22	0.61	2.43	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	7.61	1.97	0.85	1.41	2.82	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	14.56	3.86	1.49	1.49	3.27	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	10.41	2.60	1.56	0.00	5.21	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	13.61	3.54	4.25	1.56	4.11	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	14.00	3.20	3.20	2.00	4.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	1.05	0.52	1.05	2.62	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	20.00	5.96	2.98	1.24	5.72	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.82	3.48	1.74	1.09	4.56	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.95	5.74	2.44	1.59	5.98	0.61
Endothelial Cells - Vein, donor1	11267-116G7	9.10	2.28	5.69	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.26	5.59	2.79	4.89	4.89	2.10
Endothelial Cells - Vein, donor3	11416-118F3	16.17	3.14	3.30	2.04	3.93	1.41
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.48	0.49	0.49	0.49	0.49	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	2.08	0.00	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	1.64	0.82	0.82	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.58	0.55	0.44	0.22	0.22	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.81	0.33	0.11	0.54	0.87	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.83	1.70	1.46	0.97	1.21	1.58
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.64	1.36	1.36	0.14	0.68	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.66	1.48	1.27	0.63	1.16	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	24.77	1.58	0.26	1.05	1.05	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.93	2.33	1.66	1.33	0.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	10.89	1.81	0.91	0.91	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	28.80	2.27	1.52	2.27	3.79	0.76
Fibroblast - Cardiac, donor3	11417-118F4	13.88	3.00	1.89	0.79	2.05	1.10
Fibroblast - Cardiac, donor4	11452-119A3	26.98	2.73	3.03	3.33	4.24	1.52
Fibroblast - Cardiac, donor5	11456-119A7	26.40	3.05	2.16	1.90	1.14	1.14
Fibroblast - Cardiac, donor6	11460-119B2	21.07	1.82	1.67	1.21	1.52	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	28.67	1.88	2.01	3.22	4.15	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	29.77	0.86	4.31	1.29	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	1.46	0.00	0.00	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	41.98	1.85	1.38	2.77	0.46	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	30.02	3.39	3.05	1.02	2.04	0.68
Fibroblast - Dermal, donor1	11269-116G9	7.98	0.23	0.23	0.47	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	19.81	2.36	1.42	0.47	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	8.95	1.09	0.73	0.48	0.48	0.97
Fibroblast - Dermal, donor4	11450-119A1	15.26	1.02	0.68	0.45	0.34	0.68
Fibroblast - Dermal, donor5	11454-119A5	23.20	1.92	0.52	0.17	0.52	0.70
Fibroblast - Dermal, donor6	11458-119A9	24.69	0.65	0.65	0.32	0.00	1.30
Fibroblast - Gingival, donor1	11237-116D4	25.61	2.29	0.62	0.42	1.67	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.84	4.98	0.79	1.05	1.05	0.79
Fibroblast - Gingival, donor2	11318-117D4	19.11	1.45	1.32	1.19	0.53	1.05
Fibroblast - Gingival, donor3	11394-118C8	26.49	3.19	0.77	0.77	1.45	1.45
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	2.08	1.04	1.04	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	22.03	2.64	1.94	0.70	2.29	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.63	4.52	1.87	1.25	1.71	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.34	2.84	0.81	0.68	0.68	1.62
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	66.34	6.70	2.12	2.82	2.47	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	23.25	2.05	0.73	0.73	0.88	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.41	2.59	0.68	0.55	1.09	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.57	3.51	1.43	1.32	0.99	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	33.46	3.52	3.23	2.35	3.08	1.17
Fibroblast - Lung, donor1	11270-116H1	24.47	1.36	2.72	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	34.32	2.98	0.00	2.98	4.48	0.00
Fibroblast - Lung, donor3	11419-118F6	21.10	3.38	2.32	2.32	1.27	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	64.14	7.50	1.67	3.33	5.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	29.37	2.80	0.00	2.80	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	24.91	1.68	0.84	1.68	2.52	1.40
Fibroblast - Mammary, donor1	11540-120B1	34.51	4.06	1.62	2.03	2.44	0.81
Fibroblast - Mammary, donor2	11620-122A9	39.94	0.00	0.00	0.00	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	20.37	0.78	0.39	0.58	0.78	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.48	2.58	1.52	1.21	1.06	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.56	3.67	1.53	1.22	1.53	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.95	1.14	0.38	1.91	0.76	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.55	2.43	0.54	0.81	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.99	2.67	1.28	1.16	1.86	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.83	1.33	0.44	0.55	0.77	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	39.83	4.06	2.24	0.81	2.84	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	29.40	8.69	0.00	0.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.47	0.00	0.00	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	32.55	2.38	2.38	0.60	2.38	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.45	2.13	1.07	0.53	1.24	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.16	1.77	0.20	0.59	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	24.97	0.90	0.60	0.90	2.11	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	24.18	2.59	1.30	0.97	1.84	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.60	1.01	0.76	0.76	3.54	0.51
Fibroblast - skin normal, donor1	11553-120C5	17.23	2.13	0.66	0.98	1.15	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.45	1.80	1.00	0.40	1.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	19.79	1.91	1.31	0.60	2.41	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	33.55	1.21	1.51	0.91	1.81	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.24	1.82	0.25	0.83	0.75	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	30.60	3.08	2.05	2.39	1.71	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.66	1.97	0.33	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	21.30	2.88	1.81	1.17	1.60	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	21.93	1.86	1.18	0.84	1.52	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.74	0.78	0.47	0.47	1.10	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	1.74	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.67	2.25	0.35	0.35	0.69	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7.03	0.26	0.78	0.78	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.18	2.30	0.26	0.51	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.03	2.30	1.53	0.00	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	20.42	1.91	0.00	0.64	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	19.11	1.43	1.71	0.29	0.57	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.78	3.86	5.52	6.34	1.38	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.08	2.28	5.25	4.11	1.83	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	20.01	1.78	1.98	1.78	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	39.12	2.64	6.87	2.91	0.53	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.09	2.28	8.48	7.83	2.28	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.04	0.44	0.00	0.44	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	46.50	3.39	1.84	1.41	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	45.56	3.08	2.34	4.06	1.48	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	24.71	0.54	1.88	1.88	1.07	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	26.02	2.23	1.98	3.22	1.24	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.58	1.52	3.60	1.94	0.42	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	23.18	0.81	3.25	0.61	0.61	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.40	1.14	3.42	2.05	1.14	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	31.02	2.99	3.36	2.62	1.37	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	31.04	2.40	5.25	3.50	1.31	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.62	0.89	2.36	3.25	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.65	4.45	5.09	2.54	2.38	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.35	2.01	4.69	3.57	1.34	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.22	1.41	2.62	3.02	1.21	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.34	4.41	3.56	3.39	1.70	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	29.97	3.28	3.81	3.64	1.86	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	9.57	0.94	1.14	1.87	0.21	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	9.39	0.51	0.85	1.20	0.17	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	41.94	3.65	4.87	3.87	1.55	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.37	1.83	3.58	3.24	1.25	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.32	1.02	2.86	2.65	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	25.58	1.24	2.27	3.51	0.83	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	42.66	2.08	4.27	4.61	2.19	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.02	1.67	2.17	2.84	1.83	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	29.54	1.54	1.76	3.31	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	44.52	2.58	4.18	4.06	1.60	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	30.47	1.78	2.59	3.89	0.65	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	32.07	0.32	1.60	4.17	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.15	2.18	2.65	2.27	1.52	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.89	1.74	2.53	2.53	1.11	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	18.85	1.22	2.13	3.04	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.60	1.88	4.50	2.51	1.15	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.88	2.20	2.20	1.10	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.00	1.96	1.68	1.40	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.46	3.06	2.50	1.57	1.94	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	19.25	1.07	1.07	2.67	0.27	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.33	1.53	2.14	0.92	0.77	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.45	1.94	1.55	1.17	1.17	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.75	2.17	2.71	1.63	0.54	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	24.89	2.21	1.66	1.66	0.55	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.32	1.97	1.32	1.10	1.54	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	47.60	1.98	4.96	3.97	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	21.37	1.85	0.92	1.85	1.06	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.44	2.22	1.01	2.02	1.21	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	10.42	0.51	2.80	1.78	0.76	3.05
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	42.80	1.59	2.59	1.99	1.79	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	55.16	3.54	2.77	1.23	2.00	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	56.67	4.50	2.86	1.84	1.23	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.58	0.31	0.31	1.56	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.04	0.28	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	19.83	0.46	0.46	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	2.47	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.41	1.16	1.16	1.16	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	0.00	4.81	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	0.00	1.74	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	20.83	1.30	0.98	2.28	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	13.18	0.00	2.47	1.65	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	0.00	0.00	3.33	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.06	1.68	1.12	1.12	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	12.42	0.33	1.31	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	13.42	0.00	3.36	4.19	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	18.13	1.27	0.95	1.59	0.64	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.21	0.00	2.04	1.36	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.90	1.15	0.00	0.57	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.32	0.59	0.00	2.07	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	0.00	1.69	1.69	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.74	0.41	0.83	3.73	2.49	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.43	0.92	1.15	0.92	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.07	1.15	1.92	2.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.45	0.98	1.63	0.98	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	0.67	0.67	1.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	20.80	1.16	1.93	3.47	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	27.73	0.34	3.42	3.77	1.03	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	4.97	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	27.84	0.47	1.89	2.83	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.90	1.81	1.81	1.21	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	18.31	1.02	3.05	2.54	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	18.75	2.39	1.60	2.39	0.00	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	22.20	0.99	1.48	1.97	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	21.25	0.00	1.18	1.18	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.09	0.00	4.67	2.92	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.89	0.88	3.95	3.95	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	18.65	1.70	2.54	3.39	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.94	0.60	1.19	1.19	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.25	0.49	0.00	2.91	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	3.42	3.42	2.28	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.54	1.66	2.91	2.91	2.08	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	29.24	7.87	2.25	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	18.71	2.85	0.95	0.63	2.22	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.10	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.52	0.81	0.70	1.62	0.81	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.13	0.51	1.01	0.17	0.68	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.92	1.14	0.46	0.46	0.91	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.60	1.53	0.77	0.87	0.55	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.96	0.64	2.15	0.21	0.21	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.98	0.43	1.51	0.65	0.22	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.34	0.50	0.25	0.50	0.37	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	13.21	0.86	0.69	0.51	0.69	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.93	0.96	0.64	0.96	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	2.80	2.24	0.56	3.92	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.04	2.16	2.16	1.30	1.73	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	0.00	2.64	5.29	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	39.50	1.76	1.06	3.17	2.12	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	45.77	4.36	0.73	1.45	3.63	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.79	1.05	0.70	1.05	1.22	0.35
Hepatocyte, donor1	11523-119I2	4.84	0.00	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	1.08	0.00	0.00	2.15	1.08
Hepatocyte, donor3	11684-122I1	20.25	4.29	0.00	0.00	5.52	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.31	0.00	0.65	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	16.43	2.10	6.47	2.45	0.70	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	9.06	1.10	1.10	0.41	1.23	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	1.38	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	2.56	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	1.32	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.30	0.00	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	10.34	0.00	0.65	1.94	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	11.41	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.56	0.00	0.00	0.42	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	0.80	3.21	0.00	0.80	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	0.00	0.00	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.14	0.47	1.42	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	0.00	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	0.00	1.08	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	0.00	1.27	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	1.91	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	0.71	2.14	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	3.32	0.00	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.33	0.93	0.93	0.31	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	0.00	0.00	1.76	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.30	0.70	0.00	1.39	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	0.00	0.00	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	0.87	0.87	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48	3.48	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	3.20	3.20	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	0.00	0.00	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	1.06	2.11	0.00	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	12.97	1.31	0.73	0.98	0.82	0.57
Keratinocyte - epidermal, donor2	11349-117G8	12.30	2.34	0.59	0.00	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	8.90	0.66	0.76	0.28	0.09	0.38
Keratinocyte - oral, donor1	11251-116E9	22.48	2.04	1.25	1.48	0.91	0.34
Keratocytes, donor1	11527-119I6	34.04	8.60	1.72	2.06	0.69	1.03
Keratocytes, donor2	11607-120I5	31.64	3.52	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	22.13	1.78	1.19	1.98	0.99	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	22.65	2.16	1.08	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	14.88	1.38	2.19	1.73	1.15	0.46
Lens Epithelial Cells, donor3	11690-122I7	12.82	1.01	1.11	1.21	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.79	2.02	0.47	0.47	2.13	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.63	1.67	1.40	1.12	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	9.13	1.26	1.26	0.47	2.36	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	1.61	2.15	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.84	2.21	0.63	0.95	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.41	2.26	1.51	0.32	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.34	0.82	1.23	1.64	1.64	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	1.01	1.01	1.01	0.76	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.25	2.67	0.99	0.84	1.27	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.07	1.58	0.79	0.79	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.20	1.74	1.36	0.39	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.41	2.22	1.48	0.93	1.48	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	3.83	1.39	1.39	0.35	1.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.72	2.62	0.48	0.24	1.19	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.52	2.20	0.82	1.10	1.65	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.16	2.46	0.62	0.31	1.23	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	1.56	0.31	0.94	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.63	4.21	1.10	0.55	2.74	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.92	0.66	0.99	1.32	1.97	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	2.64	0.59	0.59	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.95	1.24	0.75	0.75	2.49	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.33	1.45	0.48	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	2.15	0.27	0.81	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.02	2.88	0.76	0.91	1.51	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	1.56	0.52	0.52	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	4.61	1.68	0.42	1.05	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.12	1.65	0.45	0.90	1.65	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	1.38	2.06	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	4.89	1.32	0.56	1.13	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.27	1.80	1.17	0.74	0.95	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.75	0.97	0.00	0.00	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.94	0.00	0.33	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.79	1.49	0.99	0.99	2.11	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.74	1.48	1.48	1.85	2.22	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.93	0.99	0.25	0.74	0.99	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.29	1.51	1.92	0.14	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.36	0.64	1.29	0.00	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.13	0.30	1.52	0.00	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.86	1.12	0.98	0.28	0.84	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.53	2.13	0.36	1.07	1.78	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.27	0.97	1.45	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.58	1.87	1.24	0.62	2.49	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.88	1.43	0.36	0.00	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	0.65	1.31	0.33	0.98	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.65	0.47	1.41	1.18	2.12	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.60	4.58	0.87	1.49	1.98	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.92	2.31	1.02	0.51	0.51	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	2.69	1.49	0.90	1.79	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	4.53	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	3.07	1.53	3.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.88	1.48	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.89	1.27	0.85	1.27	0.42	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	0.00	0.70	0.70	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	0.93	0.93	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	14.43	1.55	0.52	0.52	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	1.19	1.19	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.89	1.58	0.90	0.45	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.29	2.04	0.58	0.00	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	1.35	0.90	0.45	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.73	2.30	1.35	0.95	2.03	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.43	2.05	1.03	0.00	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.23	1.41	0.71	0.35	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	0.67	0.00	0.00	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	31.58	2.55	0.51	0.00	1.53	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.28	1.60	0.80	0.00	0.53	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	21.73	2.08	0.19	0.94	2.08	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.16	0.61	0.00	0.61	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	23.65	1.63	0.82	1.63	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.45	1.25	1.87	0.42	1.04	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	14.29	2.24	1.12	0.56	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	1.03	1.03	0.00	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	17.13	2.61	1.16	0.29	0.00	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.44	2.69	0.90	0.60	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.83	1.66	0.55	0.55	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	35.35	3.53	2.12	1.77	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.86	1.11	0.74	0.37	1.84	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	3.45	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.79	0.38	1.15	0.38	1.92	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	0.57	0.00	0.00	1.70	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	0.82	1.64	0.00	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.05	3.16	0.00	1.36	1.36	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.11	1.44	1.44	1.44	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	24.65	0.75	0.00	1.49	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.38	2.23	0.74	1.11	0.74	3.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.21	0.86	1.29	0.86	0.43	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	22.26	0.86	0.86	1.71	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	24.99	1.33	1.00	1.00	3.00	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	1.81	2.41	1.21	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.20	1.42	2.13	0.00	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.06	1.72	0.69	0.69	3.44	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	0.54	1.07	0.54	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	0.67	0.67	0.00	2.02	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	26.30	1.85	2.59	1.85	1.48	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	1.16	1.16	2.33	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	2.12	0.00	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	25.61	1.20	1.60	1.60	1.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	0.73	2.18	0.00	0.00	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	4.60	1.53	2.30	4.60	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.16	1.48	1.97	1.97	0.49	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	18.60	1.51	1.51	2.51	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.04	0.90	2.70	2.25	1.35	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	3.44	0.00	1.72	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.95	2.67	0.89	2.23	1.34	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.42	1.96	0.78	0.39	1.17	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	0.66	1.98	1.32	1.32	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.06	3.11	2.08	1.04	3.11	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	28.44	3.94	3.50	3.94	2.19	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	30.19	1.68	1.12	0.56	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.17	3.09	0.44	1.32	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	27.00	0.77	0.00	1.16	0.77	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.24	0.51	0.00	0.51	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.11	1.92	0.48	0.96	0.00	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.66	1.59	1.59	1.59	1.19	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.87	2.43	1.82	1.22	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.83	0.69	1.38	0.69	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.84	3.42	1.14	0.76	1.52	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	24.27	0.52	1.55	0.52	1.55	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	1.21	1.81	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.35	4.12	0.32	0.95	1.27	2.85
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.92	5.33	0.00	2.13	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.84	1.72	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.97	2.06	2.57	1.54	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	2.12	0.71	1.41	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.78	1.13	0.57	1.13	2.84	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	29.54	1.66	2.50	0.42	1.66	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	23.49	0.78	0.78	1.57	0.00	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	18.37	0.84	0.42	0.84	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	1.86	1.39	0.46	1.39	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.08	0.67	2.01	2.01	0.67	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.73	2.67	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.29	1.62	2.02	3.23	1.21	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	0.92	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	36.45	1.78	0.00	1.78	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	28.49	2.85	1.71	0.57	2.28	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	29.14	1.53	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	29.00	0.55	1.09	0.00	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	27.62	0.89	2.23	1.78	0.00	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.00	3.38	2.34	1.30	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	31.83	3.32	0.00	1.33	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	2.08	2.08	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	3.19	1.14	1.14	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	4.22	1.47	0.18	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	10.36	1.05	0.00	0.39	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.19	0.00	0.00	0.53	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	11.73	1.74	0.32	0.00	1.58	0.95
Mallassez-derived cells, donor3	11930-125I4	7.92	1.39	0.42	0.56	0.56	0.28
Mammary Epithelial Cell, donor1	11273-116H4	16.44	1.99	0.70	0.90	0.80	0.40
Mammary Epithelial Cell, donor2	11350-117G9	15.35	1.74	1.16	0.29	0.29	1.16
Mammary Epithelial Cell, donor3	11422-118F9	12.22	1.75	1.25	0.75	2.74	1.00
Mast cell - stimulated, donor1	11487-119E2	0.68	0.00	0.00	0.00	0.00	10.17
Mast cell, donor1	11563-120D6	7.35	1.62	2.16	0.97	0.43	0.22
Mast cell, donor2	11565-120D8	26.75	8.02	11.00	3.57	2.97	1.19
Mast cell, donor3	11566-120D9	40.07	7.43	18.01	6.08	4.28	1.80
Mast cell, donor4	11567-120E1	30.67	8.51	9.93	4.08	3.72	1.77
Mast cell, expanded and stimulated, donor5	11940-126A5	7.21	1.66	0.78	0.55	0.55	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	7.00	0.00	1.17	1.17	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	8.60	2.18	0.69	0.23	0.11	0.57
Mast cell, expanded, donor8	11941-126A6	14.23	2.34	3.35	1.84	1.51	1.00
Melanocyte - dark, donor1	11502-119F8	7.56	2.19	1.09	0.50	1.59	0.40
Melanocyte - dark, donor2	11582-120F7	14.88	0.69	0.69	1.04	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	18.54	2.32	1.09	0.58	0.80	0.22
Melanocyte - light, donor1	11274-116H5	25.39	3.06	1.65	0.94	1.41	1.41
Melanocyte - light, donor2	11351-117H1	27.30	2.05	1.36	1.36	1.36	0.68
Melanocyte - light, donor3	11423-118G1	18.21	2.60	1.73	0.87	1.73	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	20.72	3.64	0.52	0.21	0.62	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	12.10	0.81	0.54	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	25.98	1.61	1.34	0.80	1.87	0.27
Meningeal Cells, donor1	11493-119E8	38.33	4.47	2.48	1.24	3.23	0.50
Meningeal Cells, donor2	11573-120E7	14.97	1.32	1.76	3.08	1.76	0.88
Meningeal Cells, donor3	11654-122E7	21.35	3.02	1.30	0.73	1.22	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	18.54	1.71	1.43	1.71	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	6.44	0.50	0.81	0.40	0.30	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	46.00	3.94	5.26	2.63	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	19.62	2.62	0.00	1.31	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.76	1.44	0.72	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.85	2.75	2.12	1.48	1.27	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.13	2.51	0.50	1.01	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	25.71	1.98	1.54	0.66	0.66	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	25.57	1.46	0.73	0.73	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	26.60	2.25	1.84	0.82	1.64	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.19	1.94	0.69	1.39	2.35	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	58.73	2.97	2.60	0.74	1.86	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	29.60	3.29	1.97	0.66	0.92	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	22.26	2.37	1.78	2.37	2.67	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	0.00	7.01	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.29	0.00	0.64	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	9.92	0.00	0.00	0.71	1.42	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.77	2.50	1.25	0.63	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	6.53	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	9.55	0.80	1.06	0.53	1.06	0.53
Mesothelial Cells, donor2	12156-128G5	6.51	0.50	1.00	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	16.40	1.37	1.45	0.79	1.30	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	0.00	2.70	0.00	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	3.94	0.74	0.74	0.25	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	4.42	0.88	0.88	0.00	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	3.10	0.00	0.31	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	1.45	0.83	0.00	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	3.25	0.50	0.25	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	5.12	0.93	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	2.64	1.02	0.41	0.00	0.41	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1.58	0.40	0.00	0.40	0.00	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.56	0.76	0.00	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	2.97	0.64	0.21	0.00	0.64	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	0.92	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.79	0.60	0.30	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.26	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.85	0.24	0.24	0.24	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	0.55	0.00	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.61	0.23	0.00	0.46	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.00	0.42	0.00	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.26	0.20	0.20	0.41	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	2.57	0.00	0.21	0.21	0.21	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.00	0.44	0.67	0.44	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.10	0.44	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	0.00	1.01	0.51	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.99	0.54	0.00	0.54	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.94	0.59	0.59	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	1.09	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.20	0.40	0.80	1.20	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	1.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	1.28	0.00	0.64	1.92	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.21	0.99	0.74	0.50	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	0.70	0.00	1.39	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1.71	1.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.06	0.88	0.88	1.31	1.75	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.72	0.36	2.49	0.36	1.78	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.05	0.56	0.28	0.00	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	0.42	0.42	0.83	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	1.75	2.91	1.17	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.22	0.60	0.60	0.60	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.26	1.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	7.22	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	0.92	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.12	0.57	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.42	0.69	0.69	0.28	0.55	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.85	0.52	0.26	0.00	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.01	0.43	0.86	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	2.54	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.54	1.33	0.00	0.27	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	9.88	0.90	0.60	0.60	1.80	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.93	0.71	0.42	0.14	0.57	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.50	0.32	0.00	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.52	1.33	0.66	0.66	0.66	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.96	1.14	2.28	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.41	0.57	0.00	0.00	0.85	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.15	0.25	0.98	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	0.65	1.30	1.30	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.29	0.59	0.59	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.21	2.59	0.29	0.58	1.44	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	16.07	1.24	1.24	0.41	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.64	0.60	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2.30	0.99	0.33	0.00	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.79	0.00	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	4.66	0.00	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.88	0.75	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.66	0.27	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.36	0.11	0.23	0.00	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1.10	0.37	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.14	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.95	0.42	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	0.00	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.04	0.86	0.86	1.08	0.86	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.09	0.52	1.05	1.05	1.05	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.68	0.00	0.00	0.67	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.10	0.00	0.42	0.42	1.25	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	6.27	1.52	0.95	0.76	1.33	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	38.30	0.00	1.60	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	1.36	0.68	0.00	0.68	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.46	1.26	0.00	0.42	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.90	0.23	0.00	1.16	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.65	1.08	0.54	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	16.19	1.68	1.05	1.05	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	0.99	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.83	0.54	0.81	0.81	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.75	1.13	0.68	0.45	0.68	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.76	0.98	0.49	0.33	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	11.30	1.28	1.28	0.91	1.09	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.44	1.06	0.00	1.59	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	2.40	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.55	1.31	0.66	0.98	1.31	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.62	0.81	0.49	0.65	0.65	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	17.46	2.29	2.29	1.23	1.06	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	12.66	1.41	0.00	0.00	0.00	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	20.23	1.38	1.38	0.46	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.60	0.64	0.00	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	10.00	1.38	1.03	0.69	2.41	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	2.53	2.53	2.53	5.06	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.94	1.34	2.45	1.11	0.89	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	0.85	2.12	0.85	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.54	0.95	0.71	0.95	0.71	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.74	0.00	0.86	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	0.00	0.67	0.67	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	16.68	1.35	1.80	2.71	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	0.79	0.40	0.79	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	1.86	0.00	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.62	1.51	1.14	0.76	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.06	0.00	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.20	0.87	0.00	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.93	1.36	0.45	0.90	1.36	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	1.76	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	0.00	1.33	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	0.00	0.00	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.34	0.77	1.91	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.70	0.91	1.51	1.21	1.21	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.03	1.77	0.66	1.77	1.77	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.85	1.83	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.65	1.26	1.89	0.63	0.63	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.47	0.61	0.91	0.61	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	0.79	0.79	0.00	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	3.40	0.00	1.13	1.13	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	6.96	2.36	0.25	0.50	0.75	0.00
Myoblast, donor2	11322-117D8	15.73	0.96	0.77	0.58	1.92	1.34
Myoblast, donor3	11398-118D3	7.06	1.68	1.18	0.00	0.67	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	1.02	0.00	0.58	0.58	0.00	0.29
Natural Killer Cells, donor1	11230-116C6	2.15	0.62	1.23	0.00	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	2.71	0.60	1.51	0.00	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	2.76	0.55	2.58	0.74	0.18	0.37
Neural stem cells, donor1	11275-116H6	48.27	1.81	3.27	3.27	1.45	1.45
Neural stem cells, donor2	11352-117H2	30.81	1.93	1.93	3.85	0.00	1.93
Neurons, donor1	11494-119E9	45.52	3.41	2.28	1.14	0.00	0.00
Neurons, donor2	11574-120E8	39.85	0.44	1.98	1.32	0.66	0.44
Neurons, donor3	11655-122E8	38.64	2.47	0.82	1.64	0.82	4.11
Neutrophils, donor1	11233-116C9	0.00	0.93	0.93	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.61	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	32.77	2.73	2.97	3.56	2.14	1.66
Nucleus Pulposus Cell, donor2	11409-118E5	19.86	1.30	2.60	0.98	0.65	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	21.66	1.80	0.60	2.81	0.80	0.60
Olfactory epithelial cells, donor1	11933-125I7	21.75	2.06	1.10	0.41	0.41	0.96
Olfactory epithelial cells, donor2	11934-125I8	19.97	1.01	0.43	0.43	1.01	1.59
Olfactory epithelial cells, donor3	11935-125I9	16.57	2.84	0.79	1.25	0.34	1.02
Olfactory epithelial cells, donor4	11936-126A1	26.88	2.14	1.07	0.88	0.88	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	1.20	1.81	1.20	1.20	1.20
Osteoblast - differentiated, donor1	11276-116H7	20.42	1.28	1.49	1.91	1.70	0.64
Osteoblast - differentiated, donor2	11353-117H3	13.72	0.00	1.14	1.14	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	11.17	1.24	1.24	1.86	0.62	1.24
Osteoblast, donor1	11277-116H8	24.43	1.76	2.35	2.74	2.15	0.98
Osteoblast, donor2	11354-117H4	21.07	2.11	2.81	1.40	1.40	0.70
Osteoblast, donor3	11426-118G4	23.82	2.84	1.60	2.31	1.60	0.53
Pancreatic stromal cells, donor1	11249-116E7	17.94	1.85	1.60	1.01	1.43	0.67
Pericytes, donor1	11491-119E6	30.93	3.78	3.45	2.56	2.89	0.33
Pericytes, donor2	11571-120E5	23.09	2.49	2.94	3.62	3.40	1.81
Pericytes, donor3	11652-122E5	18.51	2.85	2.44	1.22	2.24	0.20
Perineurial Cells, donor1	11499-119F5	20.00	2.15	2.60	0.90	0.68	0.34
Perineurial Cells, donor2	11579-120F4	18.68	2.58	1.75	1.20	2.02	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	5.74	1.27	0.96	1.91	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	2.20	0.49	0.00	0.73	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	2.98	0.78	0.78	0.78	0.13	0.26
Placental Epithelial Cells, donor1	11278-116H9	5.98	0.72	2.39	1.91	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	7.76	1.11	2.22	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	14.92	1.18	3.93	3.14	0.59	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	1.58	1.58	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	8.44	0.94	0.56	0.19	0.19	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.31	1.83	0.65	0.39	0.52	0.65
Preadipocyte - breast, donor2	11328-117E5	12.16	1.58	0.68	0.45	0.68	2.03
Preadipocyte - omental, donor1	11468-119C1	11.61	1.70	1.28	0.32	0.64	0.43
Preadipocyte - omental, donor2	11329-117E6	16.15	2.62	0.87	1.75	1.75	0.00
Preadipocyte - omental, donor3	11403-118D8	18.34	3.01	1.00	1.00	1.00	0.72
Preadipocyte - perirenal, donor1	11469-119C2	19.69	0.98	2.95	0.00	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	17.20	2.15	1.84	2.46	1.54	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	15.23	1.95	1.06	0.89	1.06	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	9.37	1.02	0.85	0.34	0.68	0.85
Preadipocyte - visceral, donor1	11280-116I2	17.70	2.89	1.21	0.37	0.56	0.75
Preadipocyte - visceral, donor2	11357-117H7	17.95	1.38	0.92	0.92	0.92	3.22
Preadipocyte - visceral, donor3	11429-118G7	18.18	1.15	1.57	0.42	0.73	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	20.21	2.26	3.92	3.92	0.75	1.96
Prostate Epithelial Cells, donor2	11331-117E8	7.31	1.35	0.68	1.35	1.08	0.54
Prostate Epithelial Cells, donor3	11404-118D9	13.29	2.57	0.86	0.92	0.55	0.67
Prostate Stromal Cells, donor1	11254-116F3	18.00	1.48	0.34	0.91	1.14	0.57
Prostate Stromal Cells, donor2	11332-117E9	17.21	1.97	1.61	1.08	0.36	0.72
Prostate Stromal Cells, donor3	11405-118E1	15.85	1.77	1.56	1.46	1.25	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.39	2.92	2.55	1.09	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.08	2.22	0.90	0.62	0.76	0.42
Renal Epithelial Cells, donor1	11517-119H5	44.13	3.55	3.04	0.00	3.04	1.01
Renal Epithelial Cells, donor2	11597-120H4	19.21	3.56	2.13	0.71	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	18.21	2.43	0.95	0.42	0.64	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	1.36	4.09	2.72	3.40	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.40	2.83	1.48	1.21	2.29	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.20	1.55	2.00	0.89	2.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	2.00	1.33	2.66	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	27.51	2.20	2.20	1.10	1.10	0.44
Renal Mesangial Cells, donor2	11598-120H5	26.96	3.13	3.76	0.63	2.51	1.88
Renal Mesangial Cells, donor3	11679-122H5	26.91	3.05	2.50	1.66	1.66	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.55	2.15	0.54	1.07	2.15	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.24	1.69	0.84	0.42	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.35	3.47	2.70	1.35	1.35	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	14.26	1.04	0.78	0.78	0.78	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.17	2.56	0.85	1.71	2.84	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	1.03	2.06	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.80	1.51	0.50	0.25	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.34	7.75	2.67	1.60	3.47	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	0.00	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	9.91	0.00	0.00	0.00	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	7.54	0.58	1.74	1.74	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.80	0.65	0.78	1.17	0.52	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	7.25	0.30	0.70	0.40	0.10	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	11.27	0.56	1.34	0.22	0.67	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	10.79	0.87	1.49	0.74	0.74	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5.94	0.58	0.47	0.47	0.00	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	8.32	0.69	1.39	1.16	0.92	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.23	0.27	0.96	0.41	1.10	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.32	0.30	0.61	0.15	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	7.35	0.54	1.43	0.18	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.61	0.43	1.43	0.72	0.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	6.44	0.64	0.64	0.43	0.21	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	8.19	1.11	0.89	2.43	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.60	0.38	0.19	0.76	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.92	0.37	1.30	0.56	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.46	1.50	1.13	0.75	0.38	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.62	0.80	0.66	0.66	0.40	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	7.88	1.56	0.68	0.97	0.19	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	7.45	0.38	0.57	0.38	0.57	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.58	0.11	0.75	1.28	1.28	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.97	0.00	1.40	0.28	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	8.89	0.85	0.85	0.85	0.17	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.66	0.18	1.28	0.55	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	7.85	0.37	0.37	0.86	0.37	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	7.66	0.94	1.07	0.81	0.27	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.13	0.00	0.71	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	7.34	0.00	0.40	0.20	0.40	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	11.46	0.94	0.94	0.94	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.75	0.41	1.04	0.62	1.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	6.64	0.22	1.11	0.00	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.52	0.42	0.63	0.63	0.84	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	9.29	0.54	0.40	0.67	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.03	0.51	1.53	0.68	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	8.68	0.77	0.96	0.77	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	8.25	0.69	0.69	0.69	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	8.50	0.27	1.37	0.69	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.03	0.33	0.99	0.49	0.99	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.20	0.00	0.85	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.40	0.59	1.48	1.63	0.44	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.20	1.33	1.07	0.80	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	10.23	0.55	0.83	0.69	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	5.71	1.19	0.24	0.71	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	13.50	1.21	1.21	1.61	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.48	0.28	0.75	0.66	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	11.53	0.35	0.70	1.05	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.46	0.60	0.91	1.81	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.98	0.37	0.86	1.10	0.86	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	21.11	2.04	3.35	1.60	0.44	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.13	1.22	1.83	1.83	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.34	0.90	1.21	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	7.69	0.68	1.36	1.36	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	11.68	0.30	1.80	1.50	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	9.80	0.83	0.59	1.42	0.59	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.75	0.85	0.85	1.07	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.03	1.80	1.80	1.80	0.60	0.00
Schwann Cells, donor1	11498-119F4	35.92	1.50	1.50	0.75	1.69	1.50
Schwann Cells, donor2	11578-120F3	34.02	0.00	3.40	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	17.75	0.66	1.31	1.10	1.75	0.88
Sebocyte, donor1	11220-116B5	13.15	2.74	1.64	1.10	3.29	2.19
Sebocyte, donor2	11301-117B5	9.19	0.46	1.38	0.92	0.46	0.92
Sebocyte, donor3	11378-118B1	11.54	2.47	1.86	0.21	1.24	0.62
Sertoli Cells, donor1	11255-116F4	11.60	0.00	0.00	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	28.33	3.08	1.76	2.11	0.44	0.53
Skeletal Muscle Cells, donor2	11358-117H8	21.69	2.17	2.89	2.17	2.89	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.97	1.67	1.67	2.51	3.34	5.02
Skeletal Muscle Cells, donor4	11451-119A2	15.87	1.26	0.79	0.79	0.94	0.47
Skeletal Muscle Cells, donor5	11455-119A6	16.05	1.04	0.74	0.45	0.59	0.74
Skeletal Muscle Cells, donor6	11459-119B1	19.08	1.23	0.31	0.31	0.31	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	28.98	2.14	2.02	0.50	0.88	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.54	2.71	1.85	0.57	2.00	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	13.00	1.79	1.49	0.79	0.69	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.40	2.27	1.69	1.43	1.01	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	28.95	1.45	2.90	0.72	0.72	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.10	0.69	2.06	1.79	0.96	1.10
Skin - palm, donor1	10286-104F7	0.00	0.00	2.69	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.48	0.29	0.29	0.58	0.43	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.08	1.64	0.00	0.00	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.18	0.39	0.13	0.00	0.39	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	11.26	1.67	0.56	0.14	0.70	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	13.78	2.81	1.27	1.13	1.41	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	36.79	4.86	1.90	1.48	1.90	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	16.94	3.75	1.27	0.45	1.12	0.97
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.65	2.16	0.00	1.23	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.01	0.89	0.00	0.00	0.67	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.16	3.53	0.59	2.35	2.94	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	30.05	2.65	1.55	1.33	2.87	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.48	2.76	1.58	1.18	1.58	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	2.32	1.55	1.55	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	39.03	2.00	1.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.90	4.13	0.93	0.80	2.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.75	1.11	1.99	1.11	0.66	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1.41	0.13	0.26	0.00	0.51	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.44	0.33	0.33	0.00	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.63	1.77	0.89	0.89	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.53	1.71	1.42	1.57	0.71	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	24.56	2.28	0.98	1.30	1.46	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.18	2.74	1.52	2.13	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	25.51	3.54	1.01	2.27	1.52	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.50	0.95	1.43	1.91	1.43	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.16	1.18	0.59	0.29	0.74	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.65	0.65	1.51	1.72	1.29	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.96	1.78	1.15	0.73	0.63	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.33	2.17	1.24	1.55	1.70	1.24
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	29.10	0.00	2.16	0.00	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.92	2.39	0.30	0.60	0.60	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	38.24	4.44	1.37	1.71	1.02	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	31.33	2.43	0.94	1.10	1.02	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.63	2.62	0.60	1.51	1.21	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.98	2.50	2.05	1.82	1.59	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.17	1.81	1.21	1.81	1.81	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.81	1.06	1.59	2.12	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.17	2.13	1.73	1.20	2.26	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	20.54	2.88	1.75	1.38	1.13	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.86	1.27	0.76	1.01	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.26	3.02	1.96	0.90	1.66	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	2.25	0.00	3.00	0.00	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	266.20	3.88	3.88	1.29	5.17	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	38.60	4.19	2.33	1.40	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	2.52	0.50	0.00	3.53	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.68	2.19	1.88	1.57	2.19	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.47	2.95	1.18	0.59	4.13	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	14.16	1.83	1.33	1.42	1.08	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	0.93	1.40	1.87	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.97	1.73	1.01	1.30	1.58	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.36	4.33	1.02	1.53	2.29	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.17	1.50	0.75	0.75	2.44	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	15.37	1.96	1.40	0.70	1.12	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.31	1.26	0.75	0.50	0.92	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.90	1.43	0.48	0.00	0.95	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.68	2.94	2.94	0.73	1.96	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	16.79	2.43	1.10	0.88	1.10	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.78	2.34	0.29	0.29	0.59	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.85	2.53	0.58	0.58	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.14	0.53	0.26	0.53	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.93	0.74	0.74	0.37	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.84	1.08	1.80	2.52	1.44	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.08	1.70	0.28	1.70	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.97	1.58	0.39	0.39	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	11.68	1.02	0.76	1.02	1.27	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	19.97	0.40	0.40	2.40	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	16.30	1.25	0.42	0.84	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	11.92	0.46	1.38	0.46	1.38	1.38
Synoviocyte, donor1	11291-117A4	20.37	1.68	1.01	0.84	1.35	0.17
Synoviocyte, donor2	11368-117I9	13.07	1.51	2.51	0.84	1.17	0.84
Synoviocyte, donor3	11440-118H9	18.99	1.56	1.34	0.67	0.89	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	38.59	3.22	2.50	1.43	1.43	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	1.98	0.00	0.00	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	35.66	3.01	1.85	2.08	2.32	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	11.18	1.58	0.65	0.22	0.36	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	13.53	1.16	1.55	0.00	0.39	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	1.15	0.00	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	32.48	7.87	3.32	1.72	2.46	0.86
Urethra, donor2	10319-105A4	5.40	0.00	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	19.39	1.86	0.27	1.33	1.06	0.00
Urothelial Cells, donor2	11600-120H7	14.42	1.60	0.40	0.40	0.80	0.80
Urothelial Cells, donor3	11681-122H7	15.59	1.38	1.15	0.69	0.23	0.23
Urothelial cells, donor0	11216-116B1	21.18	1.34	0.22	0.89	1.34	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	2.67	2.67	1.78	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	4.29	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	1.37	0.00	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	4.82	2.07	1.03	0.34	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	3.49	0.00	1.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	4.16	1.04	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	3.67	0.92	1.84	0.00	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	1.83	0.91	1.83	2.74	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	15.17	1.23	0.37	1.11	0.99	1.11
Wilms' tumor cell line:HFWT	10597-108E3	41.36	0.88	2.64	3.52	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.20	1.68	1.12	1.96	0.00	1.68
achilles tendon, donor2	10292-104G4	12.40	0.00	2.07	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1.53	0.00	0.51	0.76	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4.88	0.46	2.55	0.70	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	6.65	0.24	6.17	3.68	0.24	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2.99	0.27	0.54	1.36	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	2.53	0.00	0.28	0.56	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2.96	0.21	0.85	1.27	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.62	0.54	2.45	1.09	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1.32	0.00	0.88	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	3.68	0.41	1.63	0.82	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1.16	0.39	0.78	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.29	0.00	0.37	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	3.90	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	12.08	1.16	2.79	0.93	1.39	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	8.28	1.04	0.26	0.26	0.00	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.55	1.17	0.88	0.29	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.04	0.46	0.93	0.46	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	6.58	0.82	2.06	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.53	0.00	0.00	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	4.69	0.43	0.00	0.00	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4.25	0.91	1.21	0.30	0.91	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4.81	0.48	0.24	0.24	0.96	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	4.23	0.67	0.89	0.22	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	17.34	1.00	0.33	0.67	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	3.72	13.01	5.57	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	9.04	0.38	1.88	0.75	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.78	1.31	2.18	0.44	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	30.14	2.83	1.41	0.00	0.24	0.47
adipose tissue, adult, pool1	10010-101C1	35.21	8.22	2.64	1.09	3.10	1.40
adipose, donor1	10184-103D4	32.25	4.10	8.80	7.62	1.17	1.76
adipose, donor2	10185-103D5	42.98	1.62	3.65	8.52	0.41	1.22
adipose, donor3	10186-103D6	25.32	1.63	4.08	4.90	1.09	0.82
adipose, donor4	10187-103D7	55.47	0.87	1.73	0.00	0.87	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.10	0.16	0.79	0.63	1.10	1.26
adrenal gland, adult, pool1	10081-102A9	76.39	7.28	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.94	0.80	0.53	0.27	0.00	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.58	1.79	1.07	1.79	1.07	1.07
amniotic membrane cells, donor1	12235-129G3	5.10	1.39	0.00	0.93	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	13.86	1.35	1.69	0.68	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	6.48	1.18	1.18	1.77	1.18	0.29
amygdala - adult, donor10196	10167-103B5	56.92	2.37	4.74	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	114.56	6.29	5.88	6.49	4.46	3.04
amygdala, newborn, donor10223	10360-105E9	44.54	1.94	3.23	1.94	0.00	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	28.27	3.06	0.89	0.76	0.51	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.59	1.76	0.66	1.10	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.41	2.67	9.69	5.34	1.00	1.67
aorta, adult, pool1	10052-101G7	61.39	7.45	1.77	1.37	2.94	1.37
appendix, adult	10189-103D9	27.56	3.49	2.33	1.55	2.33	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	18.92	1.38	2.06	4.82	0.69	0.34
artery, adult	10190-103E1	33.97	2.72	1.36	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	25.50	2.03	3.33	1.16	1.30	1.30
b cell line:RPMI1788	10427-106D4	2.83	0.30	1.04	0.59	0.59	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.94	1.94	0.55	0.28	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.03	3.18	1.59	0.89	1.49	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	16.07	2.34	0.50	0.17	0.50	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.36	0.56	1.68	0.56	1.12	0.56
bladder, adult, pool1	10011-101C2	67.79	8.91	3.48	2.06	1.96	1.96
blood, adult, pool1	10053-101G8	4.43	2.21	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	1.71	0.00	0.86	0.86	0.86
bone marrow, adult	10192-103E3	24.97	5.40	2.02	0.00	4.05	1.35
brain, adult, donor1	10084-102B3	77.91	4.10	6.15	4.10	0.00	2.05
brain, adult, pool1	10012-101C3	79.73	6.79	3.34	3.34	2.56	2.45
brain, fetal, pool1	10085-102B4	157.61	5.34	5.34	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	37.66	5.29	3.63	1.32	4.63	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	52.55	5.99	2.75	1.75	2.62	1.50
breast, adult, donor1	10080-102A8	42.93	9.47	1.26	2.53	2.53	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.66	2.54	1.02	1.14	0.38	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	9.28	1.55	2.47	1.55	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.19	0.69	0.92	0.00	0.46	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.53	2.42	2.91	1.45	1.94	0.97
carcinoid cell line:NCI-H1770	10703-109H1	1.41	0.47	0.47	0.00	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	20.34	3.61	3.83	3.06	1.75	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	22.82	0.32	1.58	0.00	0.95	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	32.21	1.86	4.53	5.06	0.53	3.19
caudate nucleus - adult, donor10196	10177-103C6	50.66	6.91	2.30	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	74.46	5.02	5.35	6.19	3.51	3.35
caudate nucleus, adult, donor10258	10379-105H1	39.74	6.11	0.76	1.53	0.76	3.06
caudate nucleus, newborn, donor10223	10354-105E3	61.89	1.83	1.46	1.46	1.10	1.46
cerebellum - adult, donor10196	10173-103C2	189.36	8.74	0.00	2.91	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	230.80	19.86	6.41	10.46	6.83	8.75
cerebellum, adult, pool1	10083-102B2	113.49	7.93	4.48	4.83	1.03	1.72
cerebellum, newborn, donor10223	10357-105E6	233.31	8.30	4.98	8.30	1.66	3.32
cerebral meninges, adult	10188-103D8	41.10	5.29	2.77	2.52	1.26	3.03
cerebrospinal fluid, donor2	10294-104G6	17.54	1.46	0.73	0.73	0.00	2.19
cervical cancer cell line:D98-AH2	10552-107I3	25.45	3.02	1.44	1.01	0.43	1.58
cervical cancer cell line:ME-180	10553-107I4	7.95	1.82	0.99	0.83	0.83	0.50
cervix, adult, pool1	10013-101C4	100.48	11.34	4.30	4.72	4.09	1.99
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.59	0.98	1.67	0.42	1.39	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	0.00	0.00	3.92	3.92	0.00
choriocarcinoma cell line:BeWo	10423-106C9	36.66	3.73	5.84	3.60	1.99	1.12
choriocarcinoma cell line:SCH	10785-110H2	15.28	0.99	4.68	2.22	0.99	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	30.60	2.61	2.85	3.56	2.37	0.47
chorionic membrane cells, donor1	12238-129G6	8.26	1.42	2.28	0.85	2.28	0.28
chorionic membrane cells, donor2	12239-129G7	14.02	3.18	2.29	0.89	0.70	0.50
chorionic membrane cells, donor3	12240-129G8	7.14	1.10	3.30	2.75	1.10	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.07	1.15	1.54	0.77	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.71	1.06	1.27	2.11	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.24	0.26	0.77	0.77	0.26	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	8.95	1.21	0.00	0.73	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	8.55	1.22	1.02	0.81	0.41	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	5.59	0.59	1.18	0.88	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	5.73	1.04	1.30	0.26	0.78	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	18.74	0.46	0.69	0.69	0.69	1.14
clear cell carcinoma cell line:TEN	10636-108I6	18.39	2.60	1.04	1.21	1.39	1.04
colon carcinoma cell line:CACO-2	10513-107D9	13.00	0.73	4.58	2.38	0.37	1.10
colon carcinoma cell line:COLO-320	10420-106C6	35.35	3.80	8.36	6.46	0.00	0.00
colon, adult, donor1	10082-102B1	71.40	8.33	2.38	2.38	3.57	1.19
colon, adult, pool1	10014-101C5	69.21	9.75	3.29	1.65	3.17	2.70
colon, fetal, donor1	10070-101I7	30.90	4.94	1.24	1.85	3.09	1.85
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	9.17	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1.27	0.42	0.85	0.85	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2.57	0.30	0.45	0.15	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	2.12	0.42	0.28	0.42	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	91.32	8.40	5.97	4.42	3.54	2.10
cruciate ligament, donor2	10295-104G7	12.16	0.00	1.62	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	36.12	2.41	1.61	1.61	0.80	1.61
diencephalon, adult	10193-103E4	27.84	2.40	2.40	1.44	0.96	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.92	0.23	0.00	0.46	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	50.26	6.92	3.08	0.77	0.51	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.89	1.44	1.44	1.93	0.96	0.96
ductus deferens, adult	10196-103E7	98.67	12.46	3.99	4.98	1.99	4.98
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	10.08	1.44	5.76	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.20	3.68	5.89	1.47	2.21	2.94
dura mater, adult, donor1	10041-101F5	67.89	9.00	6.52	4.87	4.87	2.31
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.99	2.44	0.89	1.33	0.89	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	22.50	1.00	1.00	1.43	0.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	20.96	1.85	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	11.81	1.51	0.61	0.30	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.82	1.23	0.93	0.62	0.93	0.31
embryonic pancreas cell line:2C6	10603-108E9	18.39	2.63	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	30.84	2.35	4.69	3.35	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	23.74	1.81	1.45	1.81	1.09	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	10.61	0.64	0.16	0.16	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	15.01	2.45	1.67	1.11	0.67	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	10.67	1.65	0.66	0.33	0.44	0.44
epididymis, adult	10197-103E8	31.82	4.40	2.30	2.09	2.30	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	8.87	0.89	0.71	0.18	0.18	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.12	0.79	0.79	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	16.38	1.70	1.18	1.44	0.79	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.88	2.36	0.89	0.79	0.69	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.21	0.67	2.02	1.23	1.01	0.78
esophagus, adult, pool1	10015-101C6	35.89	5.52	1.70	0.96	1.59	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	35.32	4.26	3.88	2.88	2.50	1.25
eye - muscle inferior rectus, donor1	10272-104E2	9.66	2.41	2.41	0.00	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	4.21	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	0.00	0.00	0.00	2.98	1.49
eye - muscle superior, donor2	10297-104G9	5.73	0.00	0.00	0.00	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	71.41	1.46	2.91	2.91	0.00	1.46
eye, fetal, donor1	10054-101G9	43.73	6.36	2.54	3.05	1.78	2.54
fibrosarcoma cell line:HT-1080	10758-110E2	13.72	1.03	1.03	0.38	0.51	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	21.84	2.14	1.42	1.42	0.95	0.47
frontal lobe, adult, pool1	10040-101F4	95.14	8.91	3.85	5.35	1.78	2.44
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.11	0.90	1.80	0.90	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	23.50	2.38	1.10	0.37	0.46	0.37
gall bladder, adult	10198-103E9	61.32	9.90	3.38	4.10	4.59	2.90
gamma delta positive T cells, donor1	11937-126A2	0.54	0.00	1.07	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.37	0.37	0.00	1.12	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.98	1.06	0.21	0.63	0.84	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	29.01	1.93	2.90	1.93	0.97	1.93
gastric cancer cell line:AZ521	10549-107H9	13.44	1.15	1.64	0.98	0.82	0.49
gastric cancer cell line:GSS	10560-108A2	8.24	0.00	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	15.08	2.28	1.83	2.06	1.83	1.60
giant cell carcinoma cell line:LU65	10487-107B1	6.31	0.34	0.00	0.34	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	31.07	1.82	2.38	0.98	1.54	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	20.95	2.24	1.25	0.50	0.75	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.87	1.27	0.84	0.95	0.53	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.95	2.25	0.56	0.56	0.70	0.56
glioblastoma cell line:T98G	10485-107A8	22.85	2.10	2.87	0.88	1.55	0.77
glioma cell line:GI-1	10413-106B8	26.07	1.76	0.59	1.46	1.76	0.59
globus pallidus - adult, donor10196	10175-103C4	35.72	0.73	0.73	2.92	1.46	1.46
globus pallidus, adult, donor10252	10161-103A8	112.77	9.76	5.13	5.86	6.10	4.39
globus pallidus, adult, donor10258	10367-105F7	53.40	1.37	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	39.97	4.26	0.53	1.07	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	0.00	2.45	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.28	0.64	0.64	1.92	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	27.55	1.38	1.38	0.92	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	27.89	1.37	0.91	0.91	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	24.48	0.64	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	20.12	0.00	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	32.92	1.37	0.69	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	54.07	1.10	3.31	1.10	5.52	1.10
hairy cell leukemia cell line:Mo	10712-109I1	0.57	0.00	0.57	0.29	0.00	0.57
heart - mitral valve, adult	10205-103F7	47.24	5.38	3.89	2.69	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	61.97	11.77	3.14	2.61	2.61	2.09
heart - tricuspid valve, adult	10207-103F9	66.61	12.49	5.00	5.00	13.32	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	32.65	3.67	1.02	1.43	2.65	1.63
heart, adult, diseased, donor1	10051-101G6	43.86	8.94	2.13	1.70	5.96	3.41
heart, adult, pool1	10016-101C7	42.78	6.90	3.68	2.99	2.30	0.69
heart, fetal, pool1	10046-101G1	51.24	8.11	4.11	4.93	1.44	1.75
hepatic mesenchymal tumor cell line:LI90	10778-110G4	20.05	4.63	0.00	0.31	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	29.73	1.19	16.65	17.84	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	7.85	1.22	2.32	1.44	0.66	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	8.37	1.09	2.67	3.28	0.49	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	7.58	0.81	2.12	1.92	0.71	0.61
hepatoma cell line:Li-7	10484-107A7	28.03	2.34	1.78	2.00	0.56	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	5.53	0.60	0.50	0.40	0.30	0.20
hippocampus - adult, donor10196	10169-103B7	74.76	1.89	1.89	2.84	3.79	1.89
hippocampus, adult, donor10252	10153-102I9	117.97	7.14	7.96	5.10	6.12	6.74
hippocampus, adult, donor10258	10374-105G5	74.69	1.49	1.00	3.98	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	54.99	1.76	0.35	2.82	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.21	0.61	2.44	0.00	1.22	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.14	0.59	1.18	0.39	0.39	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	13.46	1.02	0.00	0.00	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	0.00	2.82	1.69	0.00	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.15	1.03	3.61	2.07	0.26	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.61	1.90	2.66	0.00	1.14	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	38.54	3.21	3.50	4.96	0.58	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	37.92	1.72	3.66	5.60	1.51	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	34.20	2.92	4.17	4.17	2.09	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.60	0.47	2.60	1.89	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	21.05	0.48	3.05	3.05	1.45	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.81	2.69	1.35	0.67	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	17.53	1.25	0.31	0.47	0.47	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	18.18	1.47	0.49	0.98	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.98	0.00	0.87	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	37.80	0.95	3.44	3.63	0.38	2.48
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.89	1.31	3.92	3.49	0.44	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	44.48	1.00	2.00	3.50	0.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	41.63	1.88	3.01	4.71	0.38	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	44.56	1.36	4.09	4.09	0.91	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	40.09	0.63	3.13	2.82	0.00	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.39	1.47	1.63	2.12	0.65	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.29	1.74	3.19	4.35	1.74	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	25.11	2.39	1.49	2.69	0.00	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.65	0.74	1.11	0.74	0.18	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.96	1.14	0.86	0.57	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	21.64	2.45	1.63	1.22	0.82	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.70	1.41	2.82	0.35	1.76	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.97	0.63	0.95	3.48	0.95	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.03	1.21	3.33	0.91	0.30	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.13	3.10	2.59	6.21	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.89	0.66	3.32	4.65	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	37.45	3.08	2.05	3.85	0.77	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.96	1.79	0.26	3.32	0.51	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	33.32	3.03	6.06	3.03	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	19.16	0.67	1.34	1.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.67	0.48	1.69	0.24	0.97	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	28.97	1.78	0.00	0.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	23.41	3.41	0.49	1.46	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	35.45	0.92	3.06	3.06	0.61	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	58.56	3.25	3.25	3.25	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	28.13	1.99	2.65	2.98	0.00	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.41	4.38	5.47	5.47	1.64	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	45.96	2.53	3.98	5.07	0.00	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	50.18	2.49	1.42	3.20	0.71	3.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	1.19	2.39	2.39	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	33.99	2.17	4.47	5.55	0.95	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	18.32	0.54	1.35	1.89	0.27	1.35
immature langerhans cells, donor1	11904-125F5	5.57	1.94	7.26	3.39	0.97	0.97
immature langerhans cells, donor2	11905-125F6	6.34	0.00	2.38	1.58	1.58	1.58
insula, adult, pool1	10039-101F3	118.58	8.42	4.54	5.49	2.84	3.97
keratoacanthoma cell line:HKA-1	10791-110H8	9.75	0.98	1.30	0.33	1.30	0.65
kidney, adult, pool1	10017-101C8	31.34	6.11	2.50	1.20	2.50	0.80
kidney, fetal, pool1	10045-101F9	63.95	8.49	6.51	6.15	3.25	2.12
large cell lung carcinoma cell line:IA-LM	10509-107D5	148.13	13.63	14.77	10.37	4.83	2.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.19	1.52	0.55	0.14	0.00	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.68	1.47	1.10	1.47	0.92	0.37
left atrium, adult, donor1	10079-102A7	16.89	2.72	3.81	0.54	1.63	0.00
left ventricle, adult, donor1	10078-102A6	27.81	2.02	2.53	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	38.31	3.28	1.92	1.92	1.92	2.46
leiomyoma cell line:10964C	10569-108B2	14.37	1.80	1.08	0.36	0.72	1.44
leiomyoma cell line:15242A	10570-108B3	9.24	1.09	1.63	1.09	0.54	1.63
leiomyoma cell line:15425	10571-108B4	14.08	1.70	1.21	0.73	0.97	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	6.27	3.14	4.18	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	15.47	1.89	1.77	0.83	0.47	0.24
liposarcoma cell line:KMLS-1	10782-110G8	27.49	0.94	0.94	0.62	0.78	0.62
liposarcoma cell line:SW 872	10726-110A6	22.30	1.22	2.68	0.85	0.97	1.10
liver, adult, pool1	10018-101C9	7.45	1.94	0.49	0.16	0.49	0.00
liver, fetal, pool1	10086-102B5	8.47	1.88	0.00	1.88	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	83.41	6.71	4.08	4.08	2.33	1.75
locus coeruleus, adult, donor10252	10165-103B3	90.61	8.12	5.91	4.24	3.32	4.06
locus coeruleus, adult, donor10258	10375-105G6	39.22	1.97	1.41	1.97	0.85	0.56
locus coeruleus, newborn, donor10223	10362-105F2	47.11	2.94	0.84	1.26	1.26	2.52
lung adenocarcinoma cell line:A549	10499-107C4	10.93	0.97	0.00	0.14	0.83	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	17.92	4.14	4.83	5.52	5.52	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.58	0.92	1.19	0.26	0.53	0.13
lung, adult, pool1	10019-101D1	32.49	6.02	4.49	1.54	2.84	1.42
lung, fetal, donor1	10068-101I5	83.05	7.42	9.70	15.70	6.28	2.28
lung, right lower lobe, adult, donor1	10075-102A3	39.86	5.50	7.33	3.21	0.46	1.37
lymph node, adult, donor1	10077-102A5	16.09	1.89	2.84	0.00	1.89	0.00
lymphangiectasia cell line:DS-1	10727-110A7	3.73	0.88	1.75	1.32	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.15	0.15	0.45	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.98	2.55	1.70	2.55	1.70	0.85
mature adipocyte, donor1	12231-129F8	56.39	7.10	4.00	3.11	6.22	0.44
mature adipocyte, donor2	12232-129F9	37.15	7.89	2.08	1.04	5.19	0.21
mature adipocyte, donor3	12233-129G1	41.01	8.30	2.13	1.90	3.56	0.47
mature adipocyte, donor4	12234-129G2	54.49	8.69	3.42	1.05	5.26	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.26	6.19	3.81	1.91	2.86	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	67.68	5.64	2.26	5.64	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	132.60	9.93	4.78	6.07	4.78	4.78
medial frontal gyrus, adult, donor10258	10368-105F8	52.42	2.86	0.64	0.64	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	67.39	3.41	2.99	1.28	1.71	5.12
medial temporal gyrus - adult, donor10196	10183-103D3	81.34	4.22	1.86	3.04	0.84	4.89
medial temporal gyrus, adult, donor10252	10156-103A3	140.92	8.91	6.37	7.22	4.67	3.82
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	76.09	0.72	1.79	2.51	1.44	1.44
medulla oblongata - adult, donor10196	10174-103C3	53.87	3.89	5.19	3.24	0.65	1.95
medulla oblongata, adult, donor10252	10155-103A2	85.45	9.60	4.95	4.64	4.02	3.10
medulla oblongata, adult, pool1	10038-101F2	79.99	9.96	4.90	4.41	4.08	2.20
medulla oblongata, newborn, donor10223	10361-105F1	62.49	6.25	3.82	3.47	2.08	1.04
medulloblastoma cell line:D283 Med	10838-111E1	66.20	4.21	2.88	1.55	0.00	1.11
medulloblastoma cell line:ONS-76	10759-110E3	23.11	0.98	0.73	0.98	0.61	0.12
melanoma cell line:COLO 679	10514-107E1	16.24	1.58	0.43	1.15	0.57	0.29
melanoma cell line:G-361	10465-106H6	13.30	1.09	0.27	0.27	0.54	1.36
meningioma cell line:HKBMM	10691-109F7	26.05	2.35	0.72	0.72	0.54	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	19.39	0.88	1.76	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	24.37	1.04	3.11	2.33	0.00	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	7.67	1.23	0.61	0.15	0.92	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.72	1.45	0.91	0.91	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.97	0.41	0.41	0.41	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.92	0.98	0.84	1.12	1.12	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.28	1.35	0.58	0.58	0.77	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	0.69	0.00	1.39	3.47	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.24	1.03	0.51	0.69	1.54	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.78	1.50	0.58	0.23	0.92	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.62	0.53	0.40	1.19	0.66	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.75	0.68	0.81	0.81	1.49	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.80	1.56	1.14	0.85	1.28	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	7.58	0.99	0.99	0.33	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.82	1.11	1.11	0.55	1.25	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.03	0.00	0.35	0.00	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.51	0.41	0.41	0.00	1.02	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.55	0.72	1.44	0.36	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.48	0.52	1.03	0.31	0.31	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.66	1.14	0.46	0.00	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	11.33	1.68	0.84	1.26	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.92	1.05	0.75	1.05	1.20	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.12	0.96	0.96	0.61	0.26	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.78	0.00	0.37	0.00	0.37	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	7.73	0.57	0.29	1.14	0.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	11.79	2.95	1.26	0.84	0.42	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	1.83	1.37	0.46	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.72	0.77	0.00	0.26	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.90	2.09	0.00	0.00	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	16.94	0.92	1.23	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.94	0.71	0.71	0.47	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.54	0.68	0.68	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.54	0.79	0.79	0.79	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.97	1.85	0.00	0.00	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.86	1.73	1.15	1.15	0.58	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.94	1.12	0.45	0.45	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.74	1.20	0.96	0.24	0.24	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.73	0.73	0.73	0.73	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	1.68	0.34	0.00	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.78	1.23	0.41	0.41	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.60	1.72	0.00	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	0.00	2.73	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.72	1.30	0.97	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.53	0.00	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	0.00	0.00	0.82	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	8.55	1.55	0.39	0.39	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	0.00	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	6.52	0.00	1.19	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	0.00	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	0.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.55	0.34	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.15	2.04	0.00	0.00	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	0.00	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	1.18	0.59	0.00	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.60	1.25	0.31	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	1.34	1.34	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.70	1.38	2.07	0.00	0.69	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.30	0.49	1.48	0.49	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	0.00	1.12	1.12	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	5.72	2.54	1.27	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.07	0.81	0.00	1.21	1.21	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	2.18	2.18	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	1.27	1.27	0.00	3.80	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	22.45	1.21	3.03	1.82	4.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	9.04	4.52	0.00	9.04	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.83	3.29	0.82	2.47	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.90	1.98	0.40	0.99	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.63	2.27	0.65	0.97	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	0.00	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	18.57	0.77	0.00	1.55	5.42	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.12	1.65	1.65	1.89	1.18	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.61	1.62	0.70	0.46	0.46	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.22	0.51	0.41	0.10	0.41	0.31
mesothelioma cell line:Mero-25	10850-111F4	19.74	3.40	0.91	0.23	1.36	0.45
mesothelioma cell line:Mero-41	10851-111F5	18.34	3.91	0.49	0.24	0.49	1.47
mesothelioma cell line:Mero-48a	10852-111F6	11.07	0.44	0.66	0.89	0.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	28.38	2.37	1.58	1.31	1.84	0.53
mesothelioma cell line:Mero-83	10854-111F8	16.17	0.68	0.68	0.34	0.51	1.19
mesothelioma cell line:Mero-84	10855-111F9	18.45	0.76	1.01	0.25	1.01	1.01
mesothelioma cell line:Mero-95	10856-111G1	16.77	0.83	0.83	1.45	1.04	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	15.74	2.82	0.50	0.66	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	15.20	2.53	0.90	0.36	1.09	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	32.97	3.76	1.88	1.37	1.37	2.56
mesothelioma cell line:NCI-H28	10845-111E8	10.18	1.78	0.51	1.27	1.02	0.76
mesothelioma cell line:No36	10857-111G2	15.66	0.65	0.00	1.30	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	18.15	1.63	0.54	0.54	0.81	0.81
migratory langerhans cells, donor1	11901-125F2	5.95	1.15	1.54	0.38	1.15	0.77
migratory langerhans cells, donor2	11902-125F3	8.43	1.34	1.22	0.24	0.49	0.24
migratory langerhans cells, donor3	11903-125F4	4.13	1.26	1.08	1.08	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.65	1.63	1.63	0.65	0.33	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.90	0.42	1.06	1.06	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.75	1.38	1.61	0.00	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2.47	0.19	1.14	0.00	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	4.80	0.92	0.37	0.55	0.18	0.55
myeloma cell line:PCM6	10474-106I6	4.94	1.58	0.79	0.40	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.65	0.51	1.52	0.00	3.55	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.67	1.77	0.78	0.20	1.77	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	7.24	1.00	0.67	0.11	0.45	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.81	1.03	0.81	0.29	0.15	0.15
nasal epithelial cells, donor2	12227-129F4	22.63	1.10	0.00	0.00	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	55.44	2.30	5.75	2.07	0.69	0.46
neuroblastoma cell line:NB-1	10539-107G8	50.51	4.86	2.25	3.18	1.31	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	15.39	0.21	1.69	1.27	0.63	0.42
neuroblastoma cell line:NH-12	10555-107I6	39.88	1.86	4.66	4.29	0.19	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.80	0.95	5.69	3.56	0.47	4.98
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	42.92	1.58	2.06	2.22	0.32	2.53
neuroectodermal tumor cell line:TASK1	10774-110F9	9.66	0.20	0.81	0.60	0.20	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.34	0.64	2.54	3.18	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.83	1.86	1.06	0.53	1.33	0.80
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.86	0.00	4.74	1.35	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.01	0.80	0.80	0.80	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.52	1.92	1.92	3.21	0.96	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.61	2.63	1.31	0.79	0.79	1.05
nucleus accumbens, adult, pool1	10037-101F1	81.65	6.94	4.78	4.87	2.25	2.62
occipital cortex - adult, donor10196	10172-103C1	84.48	10.30	6.18	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	168.80	9.39	5.90	5.64	4.83	4.29
occipital cortex, newborn, donor10223	10355-105E4	108.09	4.00	0.36	2.55	0.36	2.55
occipital lobe, adult, donor1	10076-102A4	68.22	4.72	2.36	1.31	1.31	3.41
occipital lobe, fetal, donor1	10073-102A1	120.15	3.43	4.29	3.86	0.43	3.43
occipital pole, adult, pool1	10036-101E9	104.46	11.20	3.47	4.34	2.52	2.52
olfactory region, adult	10195-103E6	89.60	4.39	3.44	3.82	4.01	2.29
optic nerve, donor1	10277-104E7	54.03	4.00	2.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	17.09	3.87	1.71	1.71	1.94	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.76	0.96	1.37	0.96	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	11.51	1.35	0.85	0.68	0.17	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	17.10	1.62	1.16	0.46	0.92	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	19.70	1.47	0.00	0.29	1.18	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	20.56	2.80	2.80	0.00	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	23.33	2.12	1.48	1.70	0.42	1.27
ovary, adult, pool1	10020-101D2	99.58	8.21	4.19	4.72	3.67	1.83
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	15.40	0.92	0.55	0.92	0.37	0.18
pancreas, adult, donor1	10049-101G4	12.23	0.94	4.70	3.76	1.88	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	24.60	1.96	4.47	1.12	1.68	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	25.55	3.58	1.36	1.02	1.70	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.57	2.15	1.49	0.50	1.49	0.83
paracentral gyrus, adult, pool1	10035-101E8	86.58	8.33	3.75	3.66	2.84	2.75
parietal cortex, adult, donor10258	10373-105G4	55.05	2.20	2.20	3.67	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	72.42	2.82	0.00	3.76	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	137.67	6.27	3.71	5.13	2.00	3.42
parietal lobe, adult, pool1	10034-101E7	86.53	8.90	4.23	4.58	2.38	2.20
parietal lobe, fetal, donor1	10072-101I9	94.07	0.97	5.82	8.73	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	77.76	3.36	1.87	2.62	0.37	1.12
parotid gland, adult	10199-103F1	27.13	5.55	0.62	1.23	4.32	1.85
penis, adult	10200-103F2	42.97	6.98	5.37	2.69	1.61	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.22	0.56	1.12	2.23	0.19	2.60
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.03	3.21	1.46	1.31	1.31	0.73
pineal gland - adult, donor10196	10179-103C8	85.14	5.81	3.87	3.23	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	174.11	14.81	4.15	7.11	4.74	1.78
pineal gland, adult, donor10258	10377-105G8	70.23	7.52	3.14	2.51	1.88	1.88
pituitary gland - adult, donor10196	10180-103C9	63.74	3.04	7.08	2.02	6.07	2.02
pituitary gland, adult, donor10252	10162-103A9	155.31	9.90	8.34	12.51	4.69	4.69
pituitary gland, adult, donor10258	10378-105G9	50.22	6.81	1.70	5.96	3.40	0.85
placenta, adult, pool1	10021-101D3	33.54	6.34	2.47	2.90	2.58	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	2.52	0.00	1.19	0.93	0.13	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	24.28	1.87	1.09	1.40	1.71	0.47
pons, adult, pool1	10033-101E6	46.30	6.28	2.58	2.58	2.58	1.89
postcentral gyrus, adult, pool1	10032-101E5	98.77	9.50	4.10	3.84	2.88	3.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	8.74	0.15	1.46	0.44	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	18.33	2.00	1.27	1.09	0.73	0.00
prostate, adult, pool1	10022-101D4	69.02	8.71	5.71	3.90	2.36	1.63
putamen, adult, donor10196	10176-103C5	63.74	4.25	5.90	5.67	1.42	4.25
putamen, adult, donor10252	10152-102I8	39.21	1.96	1.96	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	1.09	1.09	2.19	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	40.35	3.62	0.72	4.11	1.69	1.45
putamen, newborn, donor10223	10365-105F5	27.74	1.50	0.75	1.50	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	28.22	1.75	3.20	4.36	1.16	0.58
rectum, fetal, donor1	10067-101I4	89.02	2.78	5.56	6.95	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	21.41	1.48	1.91	0.85	0.64	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.94	0.00	2.07	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	86.58	13.82	4.17	4.08	4.08	2.58
retinoblastoma cell line:Y79	10475-106I7	12.99	0.52	1.04	0.78	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	14.88	0.37	1.23	0.37	0.61	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	114.17	7.59	7.87	5.34	1.69	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	73.51	4.55	6.06	3.79	2.27	0.76
salivary acinar cells, donor1	11771-123I7	11.17	0.65	1.13	0.49	0.97	0.49
salivary acinar cells, donor2	11772-123I8	19.83	2.07	0.96	0.69	1.10	0.55
salivary acinar cells, donor3	11773-123I9	43.70	7.28	1.99	6.62	0.66	0.00
salivary gland, adult, pool1	10093-102C3	61.20	12.58	5.15	1.72	5.15	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	13.41	0.76	0.34	0.51	0.42	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.23	1.06	0.59	0.71	0.24	0.47
seminal vesicle, adult	10201-103F3	89.94	7.94	3.17	1.59	6.35	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.71	3.16	2.19	3.16	2.92	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.79	0.50	0.25	0.50	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	0.00	0.00	1.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.97	3.76	1.75	1.34	2.28	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	13.26	1.66	1.22	2.21	1.11	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	19.74	1.42	1.03	0.77	1.55	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	4.97	1.42	2.13	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	30.46	5.64	1.68	0.60	2.64	0.72
skeletal muscle, fetal, donor1	10066-101I3	23.12	4.02	4.02	4.02	3.02	0.00
skin, adult, donor1	10074-102A2	54.28	0.00	0.00	6.79	6.79	0.00
skin, fetal, donor1	10065-101I2	22.09	0.00	1.89	0.63	1.89	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	18.34	2.33	4.34	2.00	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	20.80	0.95	6.30	6.62	1.58	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	5.98	0.39	0.77	0.39	0.39	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	27.03	2.64	8.08	5.93	1.32	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	60.80	0.48	3.06	1.45	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	13.73	1.31	0.22	0.00	0.65	0.22
small intestine, adult, pool1	10024-101D6	41.45	7.88	2.39	2.15	3.34	1.07
small intestine, fetal, donor1	10064-101I1	19.90	1.47	1.97	1.72	0.49	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.93	2.56	1.03	0.51	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	68.75	8.53	2.58	3.62	4.91	0.78
somatostatinoma cell line:QGP-1	10781-110G7	23.85	4.82	3.22	0.80	2.41	0.00
spinal cord - adult, donor10196	10181-103D1	64.00	4.13	2.52	3.21	2.52	3.21
spinal cord, adult, donor10252	10159-103A6	104.48	13.41	3.55	2.37	4.34	0.39
spinal cord, adult, donor10258	10369-105F9	29.06	0.00	0.69	2.08	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	67.69	2.44	3.66	5.49	3.05	2.44
spinal cord, newborn, donor10223	10359-105E8	48.68	5.05	0.92	3.21	0.46	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.21	3.88	0.90	1.19	2.54	0.60
spleen, adult, pool1	10025-101D7	18.72	5.07	1.76	0.99	2.20	0.55
spleen, fetal, pool1	10044-101F8	37.03	6.20	3.65	2.54	4.05	1.35
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	2.48	0.72	0.52	0.31	0.21	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	31.14	3.23	2.28	0.95	1.33	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	23.41	3.49	1.40	1.40	1.05	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	15.64	1.56	0.78	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	21.61	2.03	0.79	0.68	0.68	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.33	0.85	2.54	0.85	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	24.12	2.12	2.12	1.27	0.85	0.85
stomach, fetal, donor1	10062-101H8	54.47	6.41	3.20	3.20	2.14	1.07
submaxillary gland, adult	10202-103F4	43.87	6.27	2.28	1.14	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	78.31	6.02	3.74	2.91	1.87	2.08
substantia nigra, adult, donor10258	10371-105G2	52.24	0.52	1.03	2.59	2.07	1.03
substantia nigra, newborn, donor10223	10358-105E7	54.41	2.83	2.12	0.71	0.00	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	22.24	0.46	3.21	0.92	0.23	2.29
temporal lobe, adult, pool1	10031-101E4	100.28	8.90	4.66	3.90	2.97	4.49
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	127.50	2.85	8.55	4.99	0.71	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	114.72	3.52	5.27	4.40	0.88	4.83
tenocyte, donor1	11763-123H8	21.99	2.09	3.14	1.05	1.75	1.75
tenocyte, donor2	11765-123I1	25.56	2.29	2.29	3.05	2.29	1.91
tenocyte, donor3	11768-123I4	15.20	0.74	0.00	0.74	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	19.89	1.87	2.38	2.21	0.68	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	54.57	4.32	9.09	7.55	2.77	3.24
teratocarcinoma cell line:PA-1	10807-111A6	15.65	1.08	1.70	1.24	0.77	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.20	4.82	3.68	3.55	2.29	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	123.66	9.45	8.70	13.61	3.40	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	95.97	12.43	18.87	27.81	12.32	3.05
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	31.59	2.93	4.23	2.61	0.65	3.26
testis, adult, pool1	10026-101D8	30.49	3.87	2.47	1.72	1.83	1.40
testis, adult, pool2	10096-102C6	28.42	1.35	0.00	0.90	0.45	1.80
thalamus - adult, donor10196	10168-103B6	55.20	4.42	1.10	5.52	1.10	0.00
thalamus, adult, donor10252	10154-103A1	96.43	9.85	4.22	4.53	2.66	3.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	6.16	0.00	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.68	1.65	0.16	0.66	0.66	0.66
thalamus, newborn, donor10223	10366-105F6	28.19	1.15	0.58	0.58	0.00	0.58
throat, adult	10209-103G2	32.71	4.74	1.50	0.50	1.25	1.50
throat, fetal, donor1	10061-101H7	39.31	3.35	3.66	3.96	1.52	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	29.41	0.79	1.19	2.19	0.00	1.39
thymus, adult, pool1	10027-101D9	4.57	0.50	1.19	1.19	0.20	0.50
thymus, fetal, pool1	10043-101F7	13.92	2.29	3.12	1.25	0.62	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.69	1.33	0.93	0.93	0.53	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	18.16	1.54	1.12	0.70	0.00	0.14
thyroid, adult, pool1	10028-101E1	55.15	9.52	4.01	3.17	3.36	1.12
thyroid, fetal, donor1	10060-101H6	73.83	7.65	6.06	4.75	3.95	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	14.19	3.26	0.23	0.70	0.70	1.16
tongue, fetal, donor1	10059-101H5	21.68	3.94	1.97	1.58	1.18	0.00
tonsil, adult, pool1	10047-101G2	19.33	3.71	2.10	2.10	1.10	1.10
trachea, adult, pool1	10029-101E2	32.47	6.30	2.29	1.96	2.45	0.57
trachea, fetal, donor1	10058-101H4	34.62	6.16	3.46	2.69	2.31	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.38	1.42	1.42	0.71	1.42	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	13.48	1.11	1.52	0.81	0.71	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	32.75	2.04	3.13	1.88	1.57	2.04
tridermal teratoma cell line:HGRT	10694-109G1	62.78	1.90	3.81	5.71	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	24.80	3.56	2.37	1.52	2.29	0.68
umbilical cord, fetal, donor1	10057-101H3	35.47	2.09	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	111.59	8.53	5.63	4.95	3.07	2.22
uterus, fetal, donor1	10055-101H1	37.88	6.14	1.54	4.10	2.56	0.51
vagina, adult	10204-103F6	118.90	13.57	7.11	7.11	3.88	2.58
vein, adult	10191-103E2	22.14	1.32	1.97	1.53	1.97	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.14	0.27	1.34	0.80	0.80	0.00